AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 292: H2051-H2059, 2007. First published January 26, 2007; doi:10.1152/ajpheart.01102.2006
0363-6135/07 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/H2051    most recent
01102.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akita, Y.
Right arrow Articles by Iwasaka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akita, Y.
Right arrow Articles by Iwasaka, T.

CALL FOR PAPERS
Oxygen Sensing: Life and Death of a Cell

Exercise-induced activation of cardiac sympathetic nerve triggers cardioprotection via redox-sensitive activation of eNOS and upregulation of iNOS

Yuzo Akita,1 Hajime Otani,1 Seiji Matsuhisa,1 Shiori Kyoi,1 Chiharu Enoki,2 Reiji Hattori,2 Hiroji Imamura,2 Hiroshi Kamihata,1 Yutaka Kimura,1 and Toshiji Iwasaka1

1Second Department of Internal Medicine, Division of Cardiology, and the 2Department of Thoracic and Cardiovascular Surgery, Kansai Medical University, Moriguchi City, Japan

Submitted 10 October 2006 ; accepted in final form 22 January 2007


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
We investigated the mechanism of exercise-induced late cardioprotection against ischemia-reperfusion (I/R) injury. C57BL/6 mice received treadmill exercise (60 min/day) for 7 days at a work rate of 60–70% maximal oxygen uptake. Exercise transiently increased oxidative stress and activated endothelial isoform of nitric oxide synthase (eNOS) during exercise and increased expression of inducible isoform of NOS (iNOS) in the heart after 7 days of exercise. The mice were subjected to regional ischemia by 30 min of occlusion of the left coronary artery, followed by 2 h of reperfusion. Infarct size was significantly smaller in the exercised mice. Ablation of cardiac sympathetic nerve by topical application of phenol abolished oxidative stress, activation of eNOS, upregulation of iNOS, and cardioprotection mediated by exercise. Treatment with the antioxidant N-(2-mercaptopropionyl)-glycine during exercise also inhibited activation of eNOS, upregulation of iNOS, and cardioprotection. In eNOS–/– mice, exercise-induced oxidative stress was conserved, but upregulation of iNOS and cardioprotection was lost. Exercise did not confer cardioprotection when the iNOS selective inhibitor 1400W was administered just before coronary artery occlusion or when iNOS–/– mice were employed. These results suggest that exercise stimulates cardiac sympathetic nerves that provoke redox-sensitive activation of eNOS, leading to upregulation of iNOS, which acts as a mediator of late cardioprotection against I/R injury.

oxidative stress; endothelial nitric oxide synthase; inducible nitric oxide synthase

ISCHEMIC HEART DISEASE is a leading cause of death in industrialized countries. Reduction of infarct size in the face of acute myocardial infarction is of prime importance in saving lives and in improving the prognosis of this devastating disease. Although several drugs such as beta-blockers and nitrates are clinically available to mitigate angina and prevent the onset of acute myocardial infarction, a prophylactic use of cardioprotective drugs that are capable of reducing infarct size in a setting of experimental myocardial infarction is limited from the medical and the economical point of view. Thus alternative strategies aimed at alleviating acute myocardial infarction are required for a prophylactic purpose.

A growing body of evidence has demonstrated that brief periods of cardiac ischemia and reperfusion exert a protective effect against subsequent lethal periods of ischemia, a phenomenon termed as ischemic preconditioning (IPC). IPC was first discovered by Murry and associates (33) and has been extensively studied by many investigators in a last two decades. It is now evident that IPC has two distinct phases: an early phase, which lasts from a few minutes to 2–3 h, and a late phase, termed late preconditioning, which develops after 12 h, peaked between 24 and 48 h, and lasts for 72–96 h (1, 2, 40). Therefore, induction of late preconditioning is a promising approach to confer cardioprotection over a prolonged period of time.

Among the maneuvers that induce late preconditioning without pharmacological tools, regular exercise may represent the most convenient and effective means. It has been demonstrated that the incidence of myocardial infarction is reduced by heavy work in men (32, 38). Although improvement of endothelial function, thereby preventing atherosclerosis and coronary occlusion, and prevention of remodeling after myocardial infarction through the expression of oxidative metabolism-related genes have at least in part been attributed to this benefit (29), delaying acute ischemic injury after coronary occlusion by a late preconditioning effect may also be responsible for improving the prognosis of myocardial infarction in these subjects. Experiments in pigs (26) and dogs (17) showed that brief episodes of tachycardia that do not induce ischemia before a prolonged coronary occlusion decrease infarct size. Subsequent experiments in rats (39) and in dogs (18) showed that brief episodes of exercise induced early as well as late preconditioning protection in magnitudes larger than that obtained with ischemia- and tachycardia-induced preconditioning. However, the exact mechanism of late preconditioning against ischemia-reperfusion (I/R) injury induced by exercise remains unclear.

Exercise increases heart rate and contractile force mainly through cardiac sympathetic nerve (CSN) activation. Increased cardiac contractile activity activates endothelial nitric oxide (NO) synthase (eNOS) by imposing shear stress on vascular endothelial cells (25). Shear stress has been shown to increase the vascular generation of reactive oxygen species by an endothelium-dependent mechanism (28). Indeed, hydrogen peroxide can increase activity and expression of eNOS in endothelial cells (10, 19). Moreover, it was recently shown that hydrogen peroxide contributes to exercise-induced upregulation of eNOS (27). On the other hand, stimulation of CSN can activate eNOS by activating beta-adrenergic receptors (9). NO presumably generated by eNOS has been demonstrated to be a trigger of late preconditioning (4). NO via the formation of reactive oxygen species activates redox-sensitive signaling modules that activate transcriptional factors with resultant upregulation of inducible NO synthase (iNOS), which plays an obligatory role in cardioprotection against I/R injury (3). Such circumstantial evidence prompted us to hypothesize that exercise induces a late preconditioning effect by primarily activating CSN, leading to redox-sensitive activation of eNOS that triggers upregulation of iNOS which acts as a mediator of cardioprotection against I/R injury.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Animals. Male eNOS knockout (eNOS–/–) mice, iNOS knockout (iNOS–/–) mice, and wild-type littermates (genetic wild-type, based on C57BL/6 background) mice (10–12 wk of age and 24–28 g body wt) were obtained from Jackson Laboratory (Bar Harbor, ME). All experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication No. 85-23, Revised 1996) and approved by the Kansai Medical University Institutional Animal Care and Use Committee.

Experimental protocol. These mice were assigned to 14 groups according to the experimental protocol as shown in Fig. 1.


Figure 1
View larger version (32K):
[in this window]
[in a new window]

  		Fig. 1. Experimental protocol. All mice were subjected to 30 min of left coronary artery occlusion followed by 2 h of reperfusion (I/R). Control Ex (–), C57BL/6 control mice with sham surgery (pericardiotomy) and no exercise; Control Ex (+), control mice with sham-operated surgery and exercised; Phenol Ex (–), mice with topical application of phenol on the heart 15 days before I/R and no exercise; Phenol Ex (+), mice with topical application of phenol 7 days before exercise; MPG Ex (–), mice treated with N-(2-mercaptopropionyl)-glycine (MPG) for 7 days and no exercise; MPG Ex (+), mice treated with MPG for 7 days before exercise; Wild Ex (–), nonexercised wild-type mice treated with a vehicle of 1400W before I/R; Wild Ex (+), exercised wild-type mice treated with a vehicle; eNOS–/– Ex (–), nonexercised endothelial nitric oxide synthase knockout (eNOS–/–) mice treated with a vehicle; eNOS–/– Ex (+), exercised eNOS–/– mice treated with a vehicle; 1400W Ex (–), nonexercised wild-type mice treated with 1400W; 1400W Ex (+), exercised wild-type mice treated with 1400W; iNOS–/– Ex (–), nonexercised inducible nitric oxide synthase knockout (iNOS–/–) mice treated with a vehicle; iNOS–/– Ex (+), exercised iNOS–/– mice treated with a vehicle.

 
Ablation of cardiac sympathetic nerve. Ablation of CSN was performed as described previously (20). Briefly, mice were anesthetized with 2% isoflurane, intubated, and artificially ventilated. The chest was opened via the fifth intercostal space. The epicardial surface of the anterior wall of the left ventricle was painted with a solution of 10% phenol and 70% ethyl alcohol in the distribution of the left anterior descending coronary artery (LAD) to interrupt the cardiac sympathetic fibers innervating that region of the heart. The phenol solution was applied with a pointed handmade cotton swab. Every precaution was taken to prevent the spread of phenol to other parts of the heart and surrounding tissues. The sham-operated control animals received thoracotomy and pericardiotomy as described above without topical application of phenol.

Measurements of norepinephrine content. To confirm the efficacy of CSN ablation, anterior wall of the left ventricle was taken 7 days after topical application of phenol. The tissue samples were homogenized with a Polytron in 10% TCA. After centrifugation of the myocardial homogenate (10,000 g, 30 min), the supernatant was neutralized and analyzed for norepinephrine by high-performance liquid chromatography (1a).

Exercise training protocol. Exercise was performed 7 days after topical application of phenol as described previously (15). The exercised animals performed 7 days of consecutive treadmill exercise (60 min/day) at an estimated work rate of 60–70% maximal oxygen uptake. Mild electrical shocks were used sparingly to motivate animals to run. Control animals did not perform treadmill exercise but were placed on a nonmoving treadmill for 60 min/day for 7 days. The antioxidant, N-(2-mercaptopropionyl)-glycine (MPG) was obtained from Sigma (Tokyo, Japan), dissolved in PBS, and injected intraperitoneally at a dose of 100 mg/kg and final volume of 0.1 ml 30 min before the animal was placed on a treadmill.

Treatment with 1400W. The iNOS selective inhibitor 1400W was purchased from Alexis (San Diego, CA), dissolved with dimethyl sulfoxide (DMSO), diluted with PBS, and injected intraperitoneally at a dose of 10 mg/kg and final volume of 0.1 ml 30 min before coronary artery occlusion. The rest of the groups received the same amount and concentration of DMSO as a vehicle.

Myocardial I/R protocol. Mice were anesthetized with a mixture of ketamine-xylazine (80 and 10 mg/kg, respectively, diluted in PBS) by an intraperitoneal route. Mice were intubated, and artificial respiration was maintained at a fraction of inspired oxygen of 0.80 by using 100 strokes/min and a 2- to 3-ml stroke volume delivered through a loose connection from the rodent ventilator.

A left thoracotomy was performed at the fifth intercostal space, and the pericardium was opened to expose the heart. The LAD was ligated 1 to 2 mm from its origin by a 7-0 silk suture with an atraumatic needle, and the ends of this ligature were passed through a small vinyl tube to form a snare. After the completion of the surgical procedure, the heart was returned to its normal position in the thorax. The thoracic cavity was covered with saline-soaked gauze to prevent the heart from drying. The animals were then allowed to stabilize for 15 min before LAD ligation. Myocardial ischemia was induced by one-stage occlusion of the LAD by pressing the polyethylene tubing against the ventricular wall and then fixing it in place by clamping the vinyl tube with a hemostat. The animals then underwent 30 min of ischemia, confirmed visually in situ by the appearance of regional epicardial cyanosis and ST-segment elevation. The myocardium was reperfused by releasing the snare gently for a period of 2 h. Successful reperfusion was confirmed by visualization of arterial blood flow through the artery and an appearance of hyperemia over the surface of the previously ischemia cyanotic segment.

Measurements of infarct size. Mice were euthanized after 2 h of reperfusion, and the left main coronary artery was religated in the same location as before. Evans blue dye (1.2 ml of a 2% solution) was injected into the carotid artery catheter into the heart to delineate the ischemic zone from the nonischemic zone. The heart was rapidly excised and serially sectioned along the long axis in 1-mm-thick sections, which were then incubated in 1.0% 2,3,5-triphenyltetrazolium chloride for 5 min at 37°C to demarcate the viable and nonviable myocardium within the risk zone. Each of the five 1-mm-thick myocardial slices was weighed and digitally photographed to determine infarct size as a percentage of risk region, and the areas of infarction, risk, and nonischemic left ventricle were assessed by a blinded observer using an image-analyzing software (Win Roof, Mitani, Fukui, Japan) and a computer-assisted planimetry.

Measurements of myocardial GSH and GSSG. Myocardial GSH and GSSG were measured using a Bioxytech GSH/GSSG-412 colorimetric assay kit from Oxis Research (Portland, OR). At an indicated time, mice were anesthetized by an overdose of pentobarbital sodium, and the heart was rapidly excised and snap frozen in liquid nitrogen. Frozen myocardial tissue samples were homogenized (g/10 ml) in 5% metaphosphoric acid. The procedure was followed as per manufacturer's instructions, and the levels were quantitated as micromolar GSH or GSSG based on standard supplied along with the kit.

Western blot analysis. Frozen myocardial tissue samples were taken as in GSH/GSSG assay, ground with a mortar and pestle, and subsequently placed into a tissue grinder containing lysis buffer containing 30 mM Tris (pH 7.4), 150 mM NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, 1 mM EDTA, 0.1 mM phenylmethylsulfonyl fluoride, and a protease inhibitor cocktail Complete (Roche Diagnostics, Mannheim, Germany). The protein concentration was determined with a Bio-Rad protein assay (Bio-Rad, Hercules, CA). The lysate samples were separated by a 7.5% SDS-PAGE, and the separated proteins were transferred to a polyvinylidene-difluoride membrane with a transfer buffer containing 25 mM Tris, 192 mM glycine, and 10% methanol. The membranes were blocked with 5% skimmed milk and incubated in primary antibodies specific for eNOS, phospho-eNOS (Ser1177), and rabbit polyclonal anti-nitrotyrosine (NT) (Cell Signaling Technology, Beverly, MA) or iNOS (Santa Cruz Biotechnology, Santa Cruz, CA), and they were subsequently incubated with a peroxidase-conjugated secondary antibodies and developed using an enhanced chemiluminescence detection system (Amersham Biosciences, Tokyo, Japan) according to the manufacturer's instructions. The immunolabeling was quantified with a densitometric analysis using Win Roof (Mitani). Equal loading of the samples and consistency in the data analysis were ensured by normalization of each immunoblot signal to the corresponding Coomassie blue stain signal as described previously (31).

NOS activity assay. iNOS activity assay was performed as described (37). In brief, the frozen heart tissues were homogenized in 4 vol of buffer containing 10 mM HEPES (pH 7.2), 0.32 M sucrose, 0.1 mM EDTA, 1 mM dithiothreitol, and a protease inhibitor cocktail. The homogenate was centrifuged, and aliquots of the supernatant were incubated for 60 min at 37°C with 1) assay cocktail containing 50 mM L-valine, 1 mM DTT, 0.1 mM NADPH, 0.1 mM tetrahydrobiopterin, 1 mM L-citrulline, 18 µM L-arginine, 2 µM L-[14C]arginine, 1 mM MgCl2, and 0.2 mM CaCl2 in 50 mM KH2PO4 (pH 7.2); 2) cocktail plus 1 mM EGTA; or 3) cocktail plus 1 mM EGTA plus 1 mM N{omega}-nitro-L-arginine methyl ester to determine the total and Ca2+-independent NOS (iNOS) activity. NOS activity was quantified by measuring L-[14C]citrulline with a liquid scintillation counter following the removal of untreated L-[14C]arginine with 50W-X8 Dowex resin (Muromachi Technos, Tokyo, Japan).

Statistical analysis. All numerical data are expressed as means ± SE. Statistical analysis of data was performed with one-way ANOVA, followed by the Bonferroni post hoc test.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Effect of topical application of phenol on norepinephrine content. Norepinephrine was completely depleted from the anterior wall of left ventricle 7 days after topical application of phenol (Fig. 2), indicating that CSN was successfully ablated by topical application of phenol. However, we were not able to detect a significant change in norepinephrine content in the control heart during and after exercise (not shown).


Figure 2
View larger version (9K):
[in this window]
[in a new window]

  		Fig. 2. Myocardial norepinephrine content. Control mice with sham-operated surgery and mice treated with topical application of phenol were euthanized 7 days later, and myocardial norepinephrine content was measured as described in the text. Each bar graph represents means ± SE of 5 experiments. *P < 0.05 compared with control.

 
Effect of topical application of phenol and MPG on exercise-induced reduction of GSH/GSSG and formation of NT. We then examined whether activation of CSN exists upstream of oxidative stress during exercise. To this end, we measured glutathione redox state (GSH/GSSG) during exercise, because changes in the GSH/GSSH accurately reflect global changes in all of the intracellular antioxidant redox systems (23). GSH/GSSG was temporarily reduced by exercise (Fig. 3A). However, it returned to the baseline level 24 h after exercise. An exercise-induced decrease in GSH/GSSG was blocked by topical application of phenol or by treatment with MPG during exercise.


Figure 3
View larger version (19K):
[in this window]
[in a new window]

  		Fig. 3. A: myocardial GSH/GSSG. B: Western blot analysis for 3-nitrotyrosine (3-NT) formation. No Ex, control mice without exercise; During Ex, mice exercised for 60 min; After Ex, mice 24 h after exercise; Phenol + Ex, mice treated with topical application of phenol and exercised for 60 min; MPG + Ex, mice treated with MPG and exercised for 60 min. Each bar graph represents means ± SE of 5 experiments. *P < 0.05 compared with No Ex; {dagger}P < 0.05 compared with During Ex.

 
We also measured 3-NT formation during exercise. Formation of 3-NT detected as a 30-kDa band was determined as a marker of oxidative-nitrosative stress (24). 3-NT in the heart was increased during exercise training but was dissipated 24 h after exercise (Fig. 3B). Exercised-induced increase in 3-NT formation was blocked by topical application of phenol or by treatment with MPG during exercise.

Effect of topical application of phenol and MPG on activation of eNOS. Phosphorylation of eNOS on Ser1177 was thought to be an indicator of Ca2+-independent activation of eNOS (16). Phosphorylation of eNOS on Ser1177 was significantly increased during exercise and was attenuated 24 h after exercise (Fig. 4A). Exercise-induced phosphorylation of eNOS was blocked by topical application of phenol or by treatment with MPG during exercise. Expression of eNOS was modestly but significantly increased 7 days after daily exercise (Fig. 4B) and remained elevated 24 h after the last exercise session. Topical application of phenol or treatment with MPG during exercise significantly inhibited expression of eNOS. Activation of eNOS was evaluated by calculating the relative ratio of phosphorylation of eNOS to total eNOS (Fig. 4C). The ratio of phosphorylation of eNOS to total eNOS was significantly increased during exercise but returned to the baseline 24 h after exercise. Topical application of phenol or treatment with MPG during exercise significantly inhibited the increase in this ratio. These results indicate that exercise produces oxidative stress by activating CSN which temporarily activates eNOS and subsequently increases expression of eNOS 7 days after exercise training.


Figure 4
View larger version (16K):
[in this window]
[in a new window]

  		Fig. 4. A: Western blot analysis for phospho-eNOS (p-eNOS). B: Western blot analysis for eNOS. C: p-eNOS-to-eNOS ratio. Experimental groups are the same as in Fig. 3. Each bar graph represents means ± SE of 5 experiments. *P < 0.05 compared with No Ex; {dagger}P < 0.05 compared with During Ex.

 
Effect of topical application of phenol and MPG on expression and activity of iNOS and infarct size. We then studied whether CSN promotes upregulation of iNOS and triggers cardioprotection after exercise. A significant increase in iNOS expression (Fig. 5A) and activity (Fig. 5B) was observed 7 days after daily exercise. Expression and activity of iNOS remained elevated 24 h after the last exercise session. Topical application of phenol or treatment with MPG during exercise inhibited the upregulation of iNOS.


Figure 5
View larger version (23K):
[in this window]
[in a new window]

  		Fig. 5. A: Western blot analysis for iNOS. B: iNOS activity. Experimental groups are the same as in Fig. 3. Each bar graph represents means ± SE of 5 experiments. *P < 0.05 compared with No Ex; {dagger}P < 0.05 compared with During Ex. C: infarct size. Experimental groups are shown in Fig. 1. Each bar graph represents means ± SE of 5 experiments. *P < 0.05 compared with Control Ex (–); {dagger}P < 0.05 compared with Control Ex (+).

 
Coronary artery occlusion was performed 24 h after the last exercise session. Infarct size measured 2 h after reperfusion following 30 min of coronary artery occlusion was significantly smaller in exercised animals (Fig. 5C). Topical application of phenol or treatment with MPG during exercise had no effect on infarct size in mice without exercise but blocked the infarct size-limiting effect of exercise.

Effect of exercise on GSH/GSSG and formation of NT in eNOS–/– and iNOS–/– mice. To investigate whether exercise-induced oxidative stress is indeed an upstream event of eNOS activation and iNOS expression, we measured GSH/GSSG and 3-NT in eNOS–/– and iNOS–/– mice. The reduced GSH/GSSG level induced by exercise was not affected in both eNOS–/– and iNOS–/– mice (Fig. 6A), suggesting that exercise-induced oxidative stress exists upstream of eNOS activation and iNOS expression. However, the increase in 3-NT formation induced by exercise was inhibited in eNOS–/– mice but not in iNOS–/– mice (Fig. 6B), suggesting that eNOS-mediated NO was necessary for 3-NT formation during exercise.


Figure 6
View larger version (18K):
[in this window]
[in a new window]

  		Fig. 6. A: myocardial GSH/GSSG. B: Western blot analysis for 3-NT formation. Experimental groups are shown in Fig. 1. Each bar graph represents means ± SE of 5 experiments. *P < 0.05 compared with Wild Ex (–); {dagger}P < 0.05 compared with Wild Ex (+).

 
Effect of exercise on expression and activity of iNOS and infarct size in eNOS–/– mice. We then investigated the role of activation of eNOS in the upregulation of iNOS and cardioprotection induced by exercise. Exercise did not increase the expression and activity of iNOS in eNOS–/– mice 24 h after the last exercise session (Fig. 7, A and B), suggesting that eNOS plays a crucial role in the upregulation of iNOS induced by daily exercise.


Figure 7
View larger version (19K):
[in this window]
[in a new window]

  		Fig. 7. A: Western blot analysis for iNOS. B: iNOS activity. C: infarct size. Experimental groups are shown in Fig. 1. Each bar graph represents means ± SE of 5 experiments. *P < 0.05 compared with Wild Ex (–); {dagger}P < 0.05 compared with Wild Ex (+).

 
In contrast to the wild-type mice, daily exercise did not reduce infarct size in eNOS–/– mice (Fig. 7C).

Effect of 1400W and iNOS gene ablation on expression and activity of iNOS and exercise-induced limitation of infarct size. We next investigated the role of iNOS in cardioprotection conferred by 7 days of exercise. Although treatment with 1400W had no effect on enhanced expression of iNOS induced by exercise (Fig. 8A), it abolished the activation of iNOS (Fig. 8B). Both the enhanced expression and activity of iNOS 24 h after the last exercise session were not observed in iNOS–/– mice (Fig. 8, A and B). Treatment with 1400W just before coronary artery occlusion or the ablation of iNOS gene had no effect on infarct size in nonexercised mice but abolished the infarct size-limiting effect of daily exercise (Fig. 8C), suggesting that an upregulation of iNOS plays a crucial role in mediating cardioprotection after daily exercise.


Figure 8
View larger version (23K):
[in this window]
[in a new window]

  		Fig. 8. A: Western blot analysis for iNOS. B: iNOS activity. C: infarct size. Experimental groups are shown in Fig. 1. Each bar graph represents means ± SE of 5 experiments. *P < 0.05 compared with Wild Ex (–); {dagger}P < 0.05 compared with Wild Ex (+).

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
We investigated the mechanism of cardioprotection conferred by daily exercise. The results suggest that exercise produces a late preconditioning effect primarily through the activation of CSN. Activation of the CSN provokes oxidative stress and transient activation of eNOS leading to upregulation of iNOS, which acts as a mediator of cardioprotection against I/R injury. The salient findings to support this hypothesis are summarized as follows: 1) exercise training at an estimated work rate of 60–70% maximal oxygen uptake reduced a GSH/GSSG level and increased 3-NT formation associated with increased eNOS activity in the heart; 2) iNOS expression and activity were increased 24 h after the last exercise session; 3) upregulation of iNOS was associated with reduced infarct size after 30 min of coronary artery occlusion followed by 2 h of reperfusion; 4) topical application of phenol depleted norepinephrine in the heart and blocked reduction of GSH/GSSG, 3-NT formation, and activation of eNOS during exercise that inhibited the upregulation of iNOS 24 h after the last exercise session and the reduction of infarct size; 5) treatment with MPG during exercise also blocked the reduction of GSH/GSSG, 3-NT formation, and activation of eNOS that inhibited the upregulation of iNOS 24 h after the last exercise session and the reduction of infarct size; 6) reduction of GSH/GSSG during exercise was not altered in eNOS–/– mice, but the upregulation of iNOS 24 h after the last exercise session and the reduction of infarct size were not observed in these mice; 7) treatment with 1400W before coronary artery occlusion abolished iNOS activation and the reduction of infarct size mediated by daily exercise training; and 8) upregulation of iNOS 24 h after the last exercise session and the reduction of infarct size were not observed in iNOS–/– mice.

The present study employed 7 days of consecutive exercise aimed at producing a significant cardioprotective effect. In a preliminary study, we adopted 1 day of exercise. Although activation of eNOS was observed during this exercise protocol, similar to that observed after 7 days of consecutive exercise, there was no significant upregulation of iNOS 24 h after exercise and no infarct size-limiting effect (Y. Akita and H. Otani, unpublished observation). We attributed the inability of 1 day of exercise to completely mimic the 7 days of consecutive exercise to the lack of increased expression of eNOS. In the present study, we demonstrated that eNOS expression was modestly but significantly increased after 7 days of consecutive exercise, whereas 1 day of exercise failed to induce an upregulation of eNOS (not shown). The increased expression of eNOS resulted in a net increase in phosphorylation of eNOS on Ser1177 despite a similar relative increase in phosphorylation of eNOS during exercise between 1 day of exercise and 7 days of consecutive exercise. Such enhanced eNOS activation during exercise by itself may not be crucial in mediating cardioprotection 24 h after the last exercise session but is capable of promoting a signal transduction pathway for expression of the iNOS gene during exercise, leading to the upregulation of iNOS and iNOS-dependent cardioprotection against I/R injury. This assumption raises an important clinical implication that daily regular exercise is necessary to provoke a powerful late preconditioning effect by increasing the expression of eNOS. It has been shown that upregulation of eNOS by regular exercise takes 10 days to several months (21). We have chosen only 7 days of consecutive exercise, because prolonged periods of regular exercise may induce innervation of CSN that had been ablated by topical application of phenol. Nevertheless, our exercise protocol induced a modest but significant upregulation of eNOS. The duration of exercise training to induce an expression of eNOS in the heart may differ because of species differences, sedentary conditions before exercise, and intensity of exercise training.

The present study suggests that oxidative stress is an upstream event of eNOS activation induced by CSN stimulation during exercise, because exercise-induced reduction of GSH/GSSG was observed in eNOS–/– mice. However, the molecular link between CSN activation and oxidative stress and between oxidative stress and activation of eNOS remains unclear. There are several lines of evidence suggesting that the molecular mechanism of exercise-induced activation of eNOS is closely related to the changes in frequency and magnitude of physical forces in the vasculature, in particular, in fluid shear stress. We could not measure hemodynamic changes during exercise in the present study simply because of a methodological reason. However, it is reasonable to speculate that exercise-induced activation of CSN increases cardiac contractility and heart rate, which in turn increases blood flow and vascular shear stress. Shear stress has been shown to increase the vascular generation of reactive oxygen species by an endothelium-dependent mechanism (28). Reactive oxygen species trigger activation of signal transduction, leading to phosphorylation of eNOS. It has been demonstrated that shear stress-induced eNOS activation does not depend on a rise of intracellular Ca2+ but is directly dependent on phosphorylation of eNOS on Ser1177 mediated by the serine/threonine protein kinase Akt (16). However, activation of eNOS through an Akt-phosphorylation-dependent pathway appears to be dependent on the degree of oxidative stress. Mild oxidative stress activates the Akt/eNOS pathway, whereas severe oxidative stress inhibits phosphorylation of eNOS by depleting cell surface thiols, suggesting that eNOS activation is exquisitely sensitive to regulation by redox signaling (34). Indeed, phosphorylation of eNOS on Ser1177 and coronary vascular diameter after reperfusion were closely related to the severity of ischemia and the degree of oxidative stress (22). It should be noted, however, that activation of Akt is not a sole mechanism for phosphorylation of eNOS. In addition to Akt, phosphorylation of eNOS is also mediated by AMP-activated protein kinase, an enzyme that is activated by vigorous exercise and ischemic stress, in the presence of Ca2+-calmodulin (11) as well as by a coordinated interaction between Akt and cAMP-dependent protein kinase, i.e., protein kinase A (8). Protein kinase A activation in endothelial cells may be mediated by increased norepinephrine release associated with CSN activation through activation of beta-adrenergic receptors and a resultant production of cAMP. Therefore, the exact mechanism of exercise-induced phosphorylation of eNOS remains to be investigated in our model.

Expression of eNOS was also found to be dependent on CSN activation and oxidative stress, because increased expression of eNOS 7 days after exercise was blocked by topical application of phenol or by treatment with MPG during exercise. The regulation of eNOS expression is highly complex. A variety of factors, such as lysophosphatidylcholine, cGMP analogs, lipoproteins, inhibitors of protein kinase C, and different cytokines, is known to alter eNOS expression (30). However, a growing body of evidence suggests that shear stress plays a crucial role in increasing the expression of eNOS induced by exercise. For example, laminar shear stress was found to provoke a robust upregulation of eNOS mRNA and protein in cultured endothelial cells (36). Moreover, it has been demonstrated that shear stress increases expression of eNOS mRNA in a vascular region that is exposed to high shear stress in vivo (12). Thus an increased intensity of physiological shear stress, as expected by activation of CSN during exercise, might increase vascular eNOS expression through oxidative stress in line with the role of shear stress in generating reactive oxygen species (28) and the role of reactive oxygen species in exercise-induced upregulation of eNOS (19).

The present study indicates that not only exercise-induced oxidative stress but also activation of eNOS is required for an upregulation of iNOS and cardioprotection. This is because an upregulation of iNOS and a reduction of infarct size were not observed in eNOS–/– mice despite a generation of oxidative stress as demonstrated by a reduction of GSH/GSSG during exercise in these mice. It has been demonstrated that eNOS-mediated formation of NO and reactive oxygen species triggers late preconditioning (13, 14). NO generated by eNOS via the formation of reactive oxygen species activates protein kinase C-{epsilon}, which activates transcriptional factors with a resultant upregulation of iNOS that plays an obligatory role in cardioprotection against I/R injury (3, 14, 35). It has been previously shown that the delayed cardioprotective effects of exercise in dogs are sensitive to aminoguanidine, an inhibitor of iNOS, suggesting that exercise-induced late preconditioning is mediated by iNOS. The results of the present study demonstrating that activation of iNOS and cardioprotection induced by daily exercise were abolished by preischemic treatment with a highly selective iNOS inhibitor, 1400W, or in iNOS knockout mice point to the same conclusion that iNOS is a mediator of late preconditioning induced by exercise. The role of iNOS as a mediator of exercise-induced late preconditioning is consistent with the hypothesis that iNOS is a common mediator of late preconditioning induced by ischemic challenges or by pharmacological agents (5, 6, 41).

In conclusion, the present study demonstrated for the first time that exercise stimulates CSN which provokes redox-sensitive activation of eNOS, leading to an upregulation of iNOS that acts as a mediator of late cardioprotection against I/R injury.


   FOOTNOTES
 

Address for reprint requests and other correspondence: H. Otani, The Cardiovascular Center, Kansai Medical Univ., 10-15 Fumizono-cho, Moriguchi City, 570-8507, Japan (e-mail: otanih{at}takii.kmu.ac.jp)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Baxter GF, Goma FM, Yellon DM. Characterization of the infarct-limiting effect of delayed preconditioning: time course and dose-dependency studies in rabbit myocardium. Basic Res Cardiol 92: 159–167, 1997.[CrossRef][Web of Science][Medline]
  2. Bohm M, Castellano M, Aqabiti-Rosei E, Flesch M, Paul M, Erdmann E. Dose-dependent dissociation of ACE-inhibitor effects on blood pressure, cardiac hypertrophy, and beta-adrenergic signal transduction. Circulation 92: 3006–3013, 1995.[Abstract/Free Full Text]
  3. Bolli R. The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview. Basic Res Cardiol 91: 57–63, 1996.[CrossRef][Web of Science][Medline]
  4. Bolli R, Manchikalapudi S, Tang XL, Takano H, Qiu Y, Guo Y, Zhang Q, Jadoon AK. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res 81: 1094–1107, 1997.[Abstract/Free Full Text]
  5. Bolli R, Dawn B, Tang XL, Qiu Y, Ping P, Xuan YT, Jones WK, Takano H, Guo Y, Zhang J. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 93: 325–338, 1998.[CrossRef][Web of Science][Medline]
  6. Bolli R. The late phase of preconditioning. Circulation 87: 972–983, 2000.
  7. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33: 1897–1918, 2001.[CrossRef][Web of Science][Medline]
  8. Boo YC, Sorescu G, Boyd N, Shiojima I, Walsh K, Du J, Jo H. Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: role of protein kinase A. J Biol Chem 277: 3388–3396, 2002.[Abstract/Free Full Text]
  9. Brixius K, Bloch W, Pott C, Napp A, Krahwinkel A, Ziskoven C, Koriller M, Mehlhorn U, Hescheler J, Fleischmann B, Schwinger RH. Mechanisms of beta 3-adrenoceptor-induced eNOS activation in right atrial and left ventricular human myocardium. Br J Pharmacol 143: 1014–1022, 2004.[CrossRef][Web of Science][Medline]
  10. Cai H, Davis ME, Drummond GR, Harrison DG. Induction of endothelial NO synthase by hydrogen peroxide via a Ca2+/calmodulin-dependent protein kinase II/janus kinase 2-dependent pathway. Arterioscler Thromb Vasc Biol 21: 1571–1576, 2001.[Abstract/Free Full Text]
  11. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, Kemp BE. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443: 285–289, 1999.[CrossRef][Web of Science][Medline]
  12. Cheng C, van Haparen R, de Waard M, van Damme LC, Tempel D, Hanemaaijer L, vas Cappellen GW, Bos J, Slager CJ, Duncker DJ, van der Steen AF, de Crom R, Krams R. Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique. Blood 106: 3691–3698, 2005.[Abstract/Free Full Text]
  13. Csonka C, Pataki T, Kovacs P, Muller SL, Schroeter ML, Tosaki A, Blasig IE. Effects of oxidative stress on the expression of antioxidative defense enzymes in spontaneously hypertensive rat hearts. Free Radic Biol Med 29: 612–619, 2000.[CrossRef][Web of Science][Medline]
  14. Dawn B, Bolli R. Role of nitric oxide in myocardial preconditioning. Ann NY Acad Sci 962: 18–41, 2002.[Web of Science][Medline]
  15. Demirel HA, Powers SK, Zergeroqlu MA, Hamilton A, Coombes J, Naito H. Short-term exercise improves myocardial tolerance to in vivo ischemia-reperfusion in the rat. J Appl Physiol 91: 2205–2212, 2001.[Abstract/Free Full Text]
  16. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601–605, 1999.[CrossRef][Medline]
  17. Domenech RJ, Macho P, Sanchez G, Liu X, Dhalla N. Tachycardia preconditions infarct size in dogs: role of adenosine and protein kinase C. Circulation 97: 786–794, 1998.[Abstract/Free Full Text]
  18. Domenech RJ, Macho P, Schwarze H, Sanchez G. Exercise induces early and late myocardial preconditioning in dogs. Cardiovasc Res 55: 561–566, 2002.[Abstract/Free Full Text]
  19. Drummond GR, Gai H, Davis ME, Ramasamy S, Harrison DG. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 86: 347–354, 2000.[Abstract/Free Full Text]
  20. Francis J, Zhang ZH, Weiss RM, Felder RB. Neural regulation of the proinflammatory cytokine response to acute myocardial infarction. Am J Physiol Heart Circ Physiol 287: H791–H797, 2004.[Abstract/Free Full Text]
  21. Green DJ, Maiorana A, O'Driscoll G, Taylor R. Effect of exercise training on endothelium-derived nitric oxide function in humans. J Physiol 561: 1–25, 2004.[Abstract/Free Full Text]
  22. Hoshino S, Kikuchi Y, Nakajima M, Kimura H, Tsuyama S, Uemura K, Yoshida K. Endothelial NO Synthase (eNOS) phosphorylation regulates coronary diameter during ischemia-reperfusion in association with oxidative stress. Free Radic Res 39: 481–489, 2005.[Web of Science][Medline]
  23. Kehrer JP, Lund LG. Cellular reducing equivalents and oxidative stress. Free Radic Biol Med 17: 65–75, 1994.[CrossRef][Web of Science][Medline]
  24. Koeck T, Fu X, Hazen SL, Crabb JW, Stuehr DJ, Aulak KS. Rapid and selective oxygen-regulated protein tyrosine denitration and nitration in mitochondria. J Biol Chem 279: 27257–27262, 2004.[Abstract/Free Full Text]
  25. Kojda G, Hambrecht R. Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res 67: 187–197, 2005.[Abstract/Free Full Text]
  26. Koning MM, Gho BC, van Klaarwater E, Opstal RL, Dunker DJ, Verdouw PD. Rapid ventricular pacing produces myocardial protection by nonischemic activation of KFormula channels. Circulation 93: 178–186, 1996.[Abstract/Free Full Text]
  27. Lauer N, Suvorava T, Ruther U, Jacob R, Meyer W, Harrison DG, Kojda G. Critical involvement of hydrogen peroxide in exercise-induced up-regulation of endothelial NO synthase. Cardiovasc Res 65: 254–262, 2005.[Abstract/Free Full Text]
  28. Laurindo FR, Pedro Mde A, Barbeiro HV, Pileggi F, Carvalho MHC, Augusto O, da Luz PL. Vascular free radical release. Ex vivo and in vivo evidence for a flow-dependent endothelial mechanism. Circ Res 74: 700–709, 1994.[Abstract/Free Full Text]
  29. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 111: 363–368, 2005.[Free Full Text]
  30. Li H, Wallerath T, Munzel T, Forstermann U. Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide 7: 149–164, 2002.[CrossRef][Web of Science][Medline]
  31. Lu K, Otani H, Yamamura T, Nakao Y, Hattori R, Ninomiya H, Osako M, Imamura H. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia. J Thorac Cardiovasc Surg 121: 137–148, 2001.[CrossRef][Web of Science][Medline]
  32. Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. N Engl J Med 329: 1677–1683, 1993.[Abstract/Free Full Text]
  33. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124–1136, 1986.[Abstract/Free Full Text]
  34. Tanaka T, Nakamura H, Yodoi J, Bloom ET. Redox regulation of the signaling pathways leading to eNOS phosphorylation. Free Radic Biol Med 38: 1231–1242, 2005.[CrossRef][Web of Science][Medline]
  35. Tang XL, Takano H, Rizvi H, Turrenz JF, Qiu Y, Wu WJ, Zhang Q, Bolli R. Oxidant species trigger late preconditioning against myocardial stunning in conscious rabbits. Am J Physiol Heart Circ Physiol 282: H281–H291, 2002.[Abstract/Free Full Text]
  36. Uematsu M, Ohara Y, Navas JP, Nishida K, Murphy TJ, Alexander RW, Nerem RM, Harrison DG. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol Cell Physiol 269: C1371–C1378, 1995.[Abstract/Free Full Text]
  37. Wakeno-Takahashi M, Otani H, Nakao S, Imamura H, Shingu K. Isoflurane induces second window of preconditioning through upregulation of inducible nitric oxide synthase in rat heart. Am J Physiol Heart Circ Physiol 289: H2585–H2591, 2005.[Abstract/Free Full Text]
  38. Willich SN, Lewis M, Lowel H, Arntz HR, Schubert F, Schroder R. Physical exertion as a trigger of acute myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group. N Engl J Med 329: 1684–1690, 1993.[Abstract/Free Full Text]
  39. Yamashita N, Hoshida S, Otsu K, Asahi M, Kuzuya T, Hori M. Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation. J Exp Med 189: 1699–1706, 1999.[Abstract/Free Full Text]
  40. Yellon DM, Baxter GF. A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection? J Mol Cell Cardiol 27: 1023–1034, 1995.[CrossRef][Web of Science][Medline]
  41. Zhao T, Xi L, Chelliah J, Levasseur JE, Kukreja RC. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A1 receptors: evidence from gene-knockout mice. Circulation 102: 902–907, 2000.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
M.-H. Huang, V. Nguyen, Y. Wu, S. Rastogi, C. Y. Lui, Y. Birnbaum, H.-Q. Wang, D. L. Ware, M. Chauhan, N. Garg, et al.
Reducing ischaemia/reperfusion injury through {delta}-opioid-regulated intrinsic cardiac adrenergic cells: adrenopeptidergic co-signalling
Cardiovasc Res, December 1, 2009; 84(3): 452 - 460.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
I. Moench, H. Prentice, Z. Rickaway, and H. Weissbach
Sulindac confers high level ischemic protection to the heart through late preconditioning mechanisms
PNAS, November 17, 2009; 106(46): 19611 - 19616.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. N. Peart and J. P. Headrick
Clinical cardioprotection and the value of conditioning responses
Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1705 - H1720.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
D. A. Brown and R. L. Moore
Perspectives in innate and acquired cardioprotection: cardioprotection acquired through exercise
J Appl Physiol, November 1, 2007; 103(5): 1894 - 1899.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/H2051    most recent
01102.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akita, Y.
Right arrow Articles by Iwasaka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akita, Y.
Right arrow Articles by Iwasaka, T.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.